FDA Adverse Event Malfunction Summary report: N

BD DISCARDIT II SYRINGE

MDR report key: 9916071 · Received April 2, 2020

Report

Report Number
3002682307-2020-00119
Event Type
Malfunction
Date Received
April 2, 2020
Date of Event
March 10, 2020
Report Date
April 6, 2020
Manufacturer
BECTON DICKINSON, S.A.
Product Code
FMF
PMA / PMN Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION: AS A SAMPLE WAS NOT AVAILABLE FOR RETURN, OUR QUALITY TEAM WAS UNABLE TO CONDUCT A THOROUGH SAMPLE INVESTIGATION. A DEVICE HISTORY RECORD REVIEW WAS PERFORMED FOR PROVIDED LOT NUMBER 1912116. THE REVIEW REVEALED ONE RELATED QUALITY NOTIFICATION DURING THE PRODUCTION PROCESS THAT MAY HAVE CONTRIBUTED TO THIS INCIDENT. DURING THE PRODUCTION PROCESS DAMAGE TO THE PLUNGER LIP WAS OBSERVED, AND THE PRODUCTION PROCESS WAS HELD FOR SEGREGATION OF FAULTY PRODUCT. THIS INCIDENT RESULTED DUE TO INCORRECT SEGREGATION OF FAULTY PRODUCT BY THE OPERATOR. WE ARE CONFIDENT THAT THIS IS AN ISOLATED INCIDENT WITH AN UNLIKELY RECURRENCE, THEREFORE, FURTHER ACTION HAS NOT BEEN DETERMINED NECESSARY.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BD DISCARDIT¿ II SYRINGE LEAKED "NACL" PAST THE PLUNGER DURING USE WHILE "SOLUPRED" WAS BEING RECONSTITUTED IN IT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM FRENCH TO ENGLISH: "WHEN RECONSTITUTING A DRUG (SOLUPRED, POWDER TO BE RECONSTITUTED) IN A 10 ML SYRINGE, LEAKAGE OF THE RECONSTITUTION (NACL) AT THE PLUNGER OF THE SYRINGE."

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE BD DISCARDIT¿ II SYRINGE LEAKED "NACL" PAST THE PLUNGER DURING USE WHILE "SOLUPRED" WAS BEING RECONSTITUTED IN IT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM (B)(6) TO ENGLISH: "WHEN RECONSTITUTING A DRUG (SOLUPRED, POWDER TO BE RECONSTITUTED) IN A 10 ML SYRINGE, LEAKAGE OF THE RECONSTITUTION (NACL) AT THE PLUNGER OF THE SYRINGE."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
382695 BD DISCARDIT II SYRINGE SYRINGE FMF BECTON DICKINSON, S.A. 1912116

Patients

Seq Age Sex Outcome Treatment
1 Other